Permeabilization of the Blood-Brain Barrier via Mucosal Engrafting: Implications for Drug Delivery to the Brain

Utilization of neuropharmaceuticals for central nervous system(CNS) disease is highly limited due to the blood-brain barrier(BBB) which restricts molecules larger than 500Da from reaching the CNS. The development of a reliable method to bypass the BBB would represent an enormous advance in neurophar...

Descripción completa

Detalles Bibliográficos
Autores principales: Bleier, Benjamin S., Kohman, Richie E., Feldman, Rachel E., Ramanlal, Shreshtha, Han, Xue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3634848/
https://www.ncbi.nlm.nih.gov/pubmed/23637885
http://dx.doi.org/10.1371/journal.pone.0061694

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3634848/
https://www.ncbi.nlm.nih.gov/pubmed/23637885
http://dx.doi.org/10.1371/journal.pone.0061694

Ejemplares similares